Navigation Links
Mylan Appoints Rajiv Malik as Executive Vice President, Head of Global Technical Operations
Date:10/2/2007

PITTSBURGH, Oct. 2 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced the appointment of Rajiv Malik as Executive Vice President in charge of Global Technical Operations. Mr. Malik has served in a similar capacity for Mylan since the Company acquired a controlling stake in Matrix Laboratories Limited (Matrix), where he is Chief Executive Officer, in January 2007.

As Head of Global Technical Operations, Mr. Malik will oversee the Company's global research and development (R&D) centers and manufacturing and distribution units, with responsibility for enhancing and rationalizing Mylan's global supply chain and expanded product pipeline, as well as leveraging Matrix, one of the world's largest suppliers of active pharmaceutical ingredients, across the enlarged company.

Mr. Malik has worked more than 24 years in the global generic pharmaceutical industry. In addition to his role at Mylan, Mr. Malik currently serves as Managing Director and Chief Executive Officer of Matrix. Prior to joining Matrix in 2005, he was Head of Global Development and Regulatory at Sandoz. He started his career in R&D at Ranbaxy Laboratories, rising to Head of Generics R&D.

Mylan's Vice Chairman and CEO Robert J. Coury commented, "Rajiv has been an invaluable addition to the Mylan management team since joining us in January. Since the close of the Matrix transaction, he has truly proven his capabilities and has been instrumental in the successful integration of Matrix. Rajiv has built an outstanding operational infrastructure that will allow us to capitalize on the efficiencies, synergies and sourcing opportunities we see from bringing together all three companies."

Mr. Malik earned his master's degree in pharm
'/>"/>

SOURCE Mylan Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Mylan Wins Its Amlodipine Case With Pfizer
2. Mylan Announces Tentative FDA Approval for Its ANDA
3. Mylan Announces Final FDA Approval for Fluoxetine Capsules
4. Where Burnt Out Executives De-stress in Natures Lap
5. Asian Business Executives Urged to Be Eco-friendly
6. BMA Welcomes Scottish Executives Move to Raise the Purchase Age of Cigarettes
7. Skin Cancer Research To Go Global
8. Dementia - a global problem
9. Obesity a global problem
10. Suggestions to reduce global heart disease burden
11. Drop in global deaths from measles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... and HOLLYWOOD, Fla., Dec. 14 ... today a definitive agreement to acquire STARLIMS ... leading provider of laboratory information management systems, ... ,, The acquisition strengthens Abbott,s competitive position ... web-based applications to help laboratories efficiently store, ...
(Date:12/14/2009)... -- The National Organization for Rare Disorders (NORD) today ... lifetime and annual health insurance caps. In a ... distributed widely on Capitol Hill, NORD said the current ... caps to continue for most Americans, contrary to what ... reform and welcomes the promises made by President Obama ...
(Date:12/14/2009)... government controlled health care, before moving to the U.S. to practice ... his new book, Health Reform: The End of the American Revolution?, ... its threat to real health care! , ... (PRWEB) ... from Minnesota, warns Americans not to sell out their liberty for ...
(Date:12/14/2009)... of Tens of Thousands of New Chronic Hepatitis ... -- Legislation approved by Congress providing for federal ... helping to reduce tens of thousands of new ... United States, the National Viral Hepatitis Roundtable ... included in the FY 2010 Consolidated Appropriations bill ...
(Date:12/14/2009)... Exercise benefited men whose disease had been treated, hadn,t ... -- Exercise appears to reduce the risk of death ... study, which began in January 1986, included 668 men ... stage III colon cancer that had not spread (nonmetastatic ... that asked them about any new cancer and disease ...
Breaking Medicine News(10 mins):Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4Health News:NORD Calls for Immediate End to Lifetime Insurance Caps 2Health News:Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America 2Health News:NVHR Applauds Congressional Action to End Federal Ban on Funding Syringe Exchange 2Health News:Physical Activity May Prolong Survival After Colon Cancer 2
... India's leading vaccine manufacturer Serum Institute of India has manufactured ... vaccines // . ,The vaccine is called Td-Vac ... adolescents and adults. The new vaccine will replace the existing ... ,Td-Vac is priced at Rs 7.50 whereas the TT ...
... health the status of industry. The positive step forward ... provided under the industrial policy. Nursing homes // and ... ,The government move is expected to give a ... state, where half the population lives below the poverty ...
... a test that can detect the Hepatitis C virus using ... of Soroka University Medical Centre // in Israel carried ... functions whose blood must be passed through a machine to ... ,Such patients have a high incidence of Hepatitis C. ...
... give a false picture about coma survival and recovery rates ... felt // by coma patients and found that the ... not true as the study show that only 8% of ... with 50% upwards in real life. ,The recovery ...
... Health experts in the United States fear that if the deadly ... risk since they are vulnerable // to the H5N1 virus. ... 70 lives in Asia and has appeared in parts of Europe ... slaughtered in an effort to contain the virus. However, experts fear ...
... University of Pennsylvania have obtained valuable insights into various ... // called functional magnetic resonance imaging. It has been ... are active during an event are re-activated when a ... study shows that, as you search for memories of ...
Other Medicine News:Health News:Magnetic Resonance Imaging Can Now Be Used For Mind Reading 2
(Date:12/14/2009)... 14 When staff from a leading ... the difficult to adjust and uncomfortable cubital tunnel ... Products, Inc. (PPI) to develop a superior alternative. ... solutions for nearly five decades, responded with the ... which it announced today. Simple to fit ...
(Date:12/14/2009)... -- Caliper Life Sciences, Inc. (Nasdaq: ... and services for drug discovery and life sciences ... sale of Xenogen Biosciences Corporation ("XenBio"), a subsidiary ... Farms, Inc. for approximately $11 million. XenBio ... acquisition of Xenogen Corporation in 2006. Caliper ...
(Date:12/14/2009)... 14 Travelers of Interstate 70 west of ... a bit more colorful when 10 multicolored art forms ... named going home , will eventually include 34 ... graduate student at Herron School of Art and Design, ... Life. ,, Eli Lilly and Company (NYSE: ...
Breaking Medicine Technology:New Cubital Tunnel Splint Specially Designed for Comfort and Less Cumbersome Fit 2Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 2Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 3Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 4Public Art to Complete Transformation of Key Gateway into Indianapolis 2Public Art to Complete Transformation of Key Gateway into Indianapolis 3Public Art to Complete Transformation of Key Gateway into Indianapolis 4New Jersey Leaders Detail Savings for Health Reform 50576 1New Jersey Leaders Detail Savings for Health Reform 50576 2New Jersey Leaders Detail Savings for Health Reform 50576 3New Jersey Leaders Detail Savings for Health Reform 50576 4Celleration Appoints Mark T Wagner President and Chief Executive Officer 50572 1Celleration Appoints Mark T Wagner President and Chief Executive Officer 50572 2Hard To Treat Diseases 28HTDS 29 Clinical Trial Update on Therapeutic effects of Combined Treatment With Ribavirin And Tiazofurin 50568 1Hard To Treat Diseases 28HTDS 29 Clinical Trial Update on Therapeutic effects of Combined Treatment With Ribavirin And Tiazofurin 50568 2
... First 30 Patients Enrolled in Ongoing Study Presented at ... ... Abbott (NYSE: ABT ) today,announced continued positive results from ABSORB, the ... eluting stent platform for the treatment of coronary,artery disease. One-year results from ...
... Dynavax,Technologies Corporation (Nasdaq: DVAX ) today reported ... allergy therapy, to subjects as,part of an environmental exposure ... 300 subjects. Subjects are being screened based on a ... to ragweed allergen in,the chamber is being used to ...
Other Medicine Technology:Abbott Announces Positive One-Year Results from the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 2Abbott Announces Positive One-Year Results from the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 3Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study 2Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study 3
The MULTI-LINK RX PENTA Coronary Stent Systems with new ACCESS-LINK Stent Design are indicated for improving coronary luminal diameter....
Take Performance to a Higher Level....
The MULTI-LINK PIXEL Coronary Stent System was designed to address the challenges of small vessel treatment in patients with abrupt or threatened abrupt closure (ATC)....
FemoStop plus system is a femoral compression system for hemostasis management. It provides a comfortable and efficient "hands off method of compressing the femoral artery and vein after diagnostic ...
Medicine Products: